Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

Curr Cardiol Rep. 2017 Jun;19(6):47. doi: 10.1007/s11886-017-0856-8.

Abstract

Purpose of review: Omega-3 fatty acids are increasingly used for the protection of cardiovascular disease. The main but not the sole mechanism of action is the reduction of triglyceride levels. In this review, we summarize the effect of omega-3 supplements on all-cause and cardiovascular mortality, myocardial infarction, and stroke from the relevant randomized controlled trials.

Recent findings: Twenty-one randomized controlled trials assessed omega-3 supplementation on mortality and cardiovascular-related outcomes. From these studies, as well as from the relevant meta-analyses, we found that omega-3 supplements do not exert a consistent benefit for cardiovascular protection. There is uncertainty of a clear profit from omega-3 supplementation in cardiovascular disease.

Keywords: Cardiovascular; Death; Fish oil; Myocardial infarction; Omega 3; Polyunsaturated fatty acids.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / prevention & control*
  • Cause of Death
  • Dietary Supplements*
  • Fatty Acids, Omega-3 / administration & dosage*
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / prevention & control
  • Randomized Controlled Trials as Topic
  • Stroke / mortality
  • Stroke / prevention & control
  • Triglycerides / blood

Substances

  • Fatty Acids, Omega-3
  • Triglycerides